The NCI Outstanding Investigator Award (OIA) aims to support accomplished researchers with exceptional productivity in cancer research. This grant allows investigators to take risks, explore new ideas, or develop innovative techniques. The grant provides long-term funding stability to encourage groundbreaking projects that could advance cancer research. Institutions can nominate established Program Directors/Principal Investigators for this award, which seeks to propel discoveries in biomedical, behavioral, or clinical cancer research. The objective is to foster high-risk, high-reward research projects that have the potential to make significant contributions to the field. Closing date: November 6, 2019.
Opportunity ID: 319622
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-349 |
| Funding Opportunity Title: | NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 16, 2019 |
| Last Updated Date: | Aug 16, 2019 |
| Original Closing Date for Applications: | Nov 06, 2019 |
| Current Closing Date for Applications: | Nov 06, 2019 |
| Archive Date: | Dec 12, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $600,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Public housing authorities/Indian housing authorities Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments For profit organizations other than small businesses Independent school districts Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research. The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA. It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-349.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00253939 | Oct 06, 2019 | Nov 06, 2019 | View |
Package 1
Mandatory forms
319622 RR_SF424_2_0-2.0.pdf
319622 PHS398_CoverPageSupplement_4_0-4.0.pdf
319622 RR_OtherProjectInfo_1_4-1.4.pdf
319622 PerformanceSite_2_0-2.0.pdf
319622 RR_KeyPersonExpanded_2_0-2.0.pdf
319622 RR_Budget10_1_4-1.4.pdf
319622 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
319622 RR_SubawardBudget10_30_1_4-1.4.pdf
319622 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
